SCHEMBL6618

SCHEMBL6618

N#CC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1343696 1.00 KDM4E (0.34)
SCHEMBL1164553 1.00 KDM4E (0.34)
SCHEMBL45941 1.00 KDM4E (0.34)
Hydrochloric Acid SCHEMBL1200019 0.96
SCHEMBL28386367 0.96
Ammonia Solution, Strong SCHEMBL16007514 0.96
Hydrochloric Acid SCHEMBL5048648 0.92
SCHEMBL820230 0.89 KDM4E (0.31)
SCHEMBL820635 0.89 KDM4E (0.31)
SCHEMBL2154068 0.89 KDM4E (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5885 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6372916-B1 None US claimed
EP-4746963-A1 MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2026-05-27 EP claimed
CN-122071459-A Heterocyclic derivative containing oxazole or salt acceptable as pesticide, composition and application thereof 沈阳禧沅峰生物科技有限公司 2026-05-22 CN claimed
EP-4041730-B1 SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2026-05-13 EP claimed
EP-3856179-B1 MONOACYLGLYCEROL LIPASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2026-05-13 EP claimed
EP-4076459-B1 PRMT5 INHIBITORS MERCK SHARP & DOHME LLC (US) 2026-04-29 EP claimed
EP-4142874-B1 PYRIMIDIN-4(3H)-ONE DERIVATIVES AS TRPV4 ANTAGONISTS RAQUALIA PHARMA INC (JP) 2026-04-22 EP claimed
EP-3623372-B1 PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS VALO HEALTH INC (US) 2026-02-04 EP claimed
US-12540131-B2 N-(heteroaryl) quinazolin-2-amine derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof MERCK SHARP & DOHME LLC (US) 2026-02-03 US claimed
EP-4436667-B1 PIPERAZINYLSULFONYLARYL COMPOUNDS FOR TREATMENT OF BACTERIAL INFECTIONS HOFFMANN LA ROCHE (CH) 2026-01-21 EP claimed
EP-0296749-A1 (Substituted aralkyl) heterocyclic compounds ZENECA LIMITED (GB) 1988-12-28 EP claimed
EP-0070608-B1 PHOTOISOMERISATION OF TRANS-CYCLOPROPANE-NITRILES SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1985-01-16 EP claimed
US-4421618-A CONVERSION TO CIS ISOMER SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B. V. (NL) 1983-12-20 US claimed
EP-0070608-A1 Photoisomerisation of trans-cyclopropane-nitriles SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1983-01-26 EP claimed
EP-0002077-B1 ESTERS OF SUBSTITUTED CYCLOPROPANECARBOXYLIC ACIDS AND PROCESS FOR THE PREPARATION THEREOF SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1981-09-02 EP claimed
US-4236018-A Process for preparing cyclopropane carboxylic acids IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1980-11-25 US claimed
US-4205009-A USING ANIONIC SURFACTANT VELSICOL CHEMICAL CORPORATION (US) 1980-05-27 US claimed
US-4174348-A Preparation of cyclopropanecarbonitriles SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B. V. (NL) 1979-11-13 US claimed
EP-0002077-A1 Esters of substituted cyclopropanecarboxylic acids and process for the preparation thereof SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1979-05-30 EP claimed
US-3974199-A Process for production of cyclopropylcyanide THE DOW CHEMICAL COMPANY (US) 1976-08-10 US claimed